Average lifespan shortened due to Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma, and leukemia in Japan, 1990–2015

References

• Hori M, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45(9):884–891.
   PubMed Web of Science ®Google Scholar
• Chihara D, Ito H, Matsuda T, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164(4):536–545.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2197–2223.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;349(9064):1498–1504.
   PubMed Web of Science ®Google Scholar
• Pham TM, Shack L, Cheung WY. Introduction of a novel measure of premature mortality caused by chronic conditions: real-world examples from prostate and testis cancers in Canada, 1980–2015. Ann Epidemiol. 2019;37:81–83.
   PubMed Web of Science ®Google Scholar
• Pham TM, Sikdar KC, Kaposhi B, et al. Premature mortality due to breast cancer among Canadian women: an analysis of a 30-year period from 1980 through 2010. Eur J Public Health. 2018;28(2):348–352.
   PubMed Web of Science ®Google Scholar
• Atchison KM, Pham TM, Sikdar KC, et al. Premature deaths due to head and neck cancers in Canada: a nationwide analysis from 1980 to 2010. Laryngoscope. 2020;130(4):911–917.
   PubMed Web of Science ®Google Scholar
• Pham TM, Sikdar KC, Cheung WY, et al. Premature mortality due to malignancies of the central nervous system in Canada, 1980–2010. Neuroepidemiology. 2018;50(3–4):195–200.
   PubMed Web of Science ®Google Scholar
• Pham TM, Shen-Tu G, Nguyen KH, et al. Premature mortality due to Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma, and leukemia in Canada: a nationwide analysis from 1980 to 2015. Am J Epidemiol. 2021;190(1):59–75.
   PubMed Web of Science ®Google Scholar
• Pham TM, Thanh NX, Wasylak T, et al. Average lifespan shortened due to stroke in Canada: a nationwide descriptive study from 1990 to 2015. Stroke. 2021;52(2):573–581.
   PubMed Web of Science ®Google Scholar
• Pham TM, Kubo T, Fujino Y, et al. Premature mortality due to malignancies of the kidney and bladder in Japan, 1980–2010. J Epidemiol. 2019;29(12):464–470.
   PubMed Web of Science ®Google Scholar
• Pham TM, Quy PN, Horimatsu T, et al. Premature mortality due to stomach cancer in Japan: a nationwide analysis from 1980 to 2015. Ann Epidemiol. 2020;47:19–24.
   PubMed Web of Science ®Google Scholar
• Pham TM, Nguyen DK, Pham HM, et al. Average lifespan shortened due to breast cancer in Australia, 1990–2015. Breast Cancer. 2021;28(6):1389–1391.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO statistical information system. WHO mortality database; 2021 [cited 2021 Apr 12]. Available from: http://www.who.int/healthinfo/mortality_data/en/
   Google Scholar
• Burnet NG, Jefferies SJ, Benson RJ, et al. Years of life lost (YLL) from cancer is an important measure of population burden-and should be considered when allocating research funds. Br J Cancer. 2005;92(2):241–245.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyashiro I, Ito H, et al. Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. Cancer Sci. 2014;105(11):1480–1486.
   PubMed Web of Science ®Google Scholar
• Foundation for Promotion of Cancer Research. Cancer statistics in Japan – 2021. Tokyo, Japan; 2021. Available from: https://ganjoho.jp/public/qa_links/report/statistics/2021_en.html2021
   Google Scholar
• Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) Co-Operative Group. Br J Haematol. 1976;33(4):451–458.
   PubMed Web of Science ®Google Scholar
• Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84(5):1361–1392.
   PubMed Web of Science ®Google Scholar
• Werdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Vol. 2. Lyon, France: WHO Press; 2017.
   Google Scholar
• Nagai H, Yano T, Watanabe T, et al. Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma. Br J Haematol. 2008;143(5):672–680.
   PubMed Web of Science ®Google Scholar
• Hatta Y, Mizuta S, Matsuo K, et al. Final analysis of the JALSG Ph + ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph + ALL. Ann Hematol. 2018;97(9):1535–1545.
   PubMed Web of Science ®Google Scholar
• Takeuchi J, Kyo T, Naito K, et al. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study. Leukemia. 2002;16(7):1259–1266.
   PubMed Web of Science ®Google Scholar
• Jinnai I, Sakura T, Tsuzuki M, et al. Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study. Int J Hematol. 2010;92(3):490–502.
   PubMed Web of Science ®Google Scholar
• Suzuki K. Current therapeutic strategy for multiple myeloma. Jpn J Clin Oncol. 2013;43(2):116–124.
   PubMed Web of Science ®Google Scholar
• Torimoto Y, Shindo M, Ikuta K, et al. Current therapeutic strategies for multiple myeloma. Int J Clin Oncol. 2015;20(3):423–430.
   PubMed Web of Science ®Google Scholar
• Bataillard EJ, Cheah CY, Maurer MJ, et al. Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review. Blood Adv. 2021;5(9):2426–2437.
   PubMed Web of Science ®Google Scholar
• The Japanese Data Center for Hematopoietic Cell Transplantation. The Japan Society for Hematopoietic Cell Transplantation. Hematopoietic cell transplantation in Japan. Annual report of nationwide survey 2015. ISSN 1344-5898 monograph. Vol. 41; 2015.
   Google Scholar